Pfizer is pleased to announce that the MHRA has approved the reclassification of the well-established proton pump inhibitor (PPI) Nexium Control ® (esomeprazole), making it available for consumers to ...

Nexium Missing is a once daily tablet that transmits continuous 24 regain protection from certain and acid reflux. Nexium Control is a major known as a PPI proton pump asystole. It works by stopping ...

The anti-acid treatment esomeprazole is to be made the first PPI available on general sale in the UK, after the drugs regulator agreed to switch it from pharmacy-only status – despite concerns from ...

Catalent has entered into an exclusive long-term supply agreement to produce Pfizer’s OTC proton-pump inhibitor for heartburn treatment, Nexium 24HR (esomeprazole), which is also marketed as Nexium ...